ethyl 5-phenethyl-4,5-dihydroisoxazole-3-carboxylate | 147007-99-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑啉类
• 英文名称: ethyl 5-phenethyl-4,5-dihydroisoxazole-3-carboxylate
• 英文别名: ethyl 5-cyclohexyl-4,5-dihydroisoxazole-3-carboxylate；Ethyl 5-cyclohexyl-4,5-dihydroisoxazole-3-carboxylate；ethyl 5-cyclohexyl-4,5-dihydro-1,2-oxazole-3-carboxylate
• CAS: 147007-99-6
• 化学式: C₁₂H₁₉NO₃
• 分子量: 225.288
• InChiKey: PCNQVHTUZWZHPB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  47.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 5-phenethyl-4,5-dihydroisoxazole-3-carboxylate 在 乙酸乙酯 、 crude material 作用下， 以 sodium hydroxide 、 1,4-二氧六环 为溶剂， 反应 16.0h， 生成 5-cyclohexyl-4,5-dihydroisoxazole-3-carboxylic acid
  参考文献：
  名称：

  INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

  摘要：

  该发明提供了新型化合物，以及这些新型化合物用作药物，特别是用于预防或治疗神经退行性疾病，更具体地说是某些神经系统疾病，例如被统称为tau病理学的疾病，以及由细胞毒性α-突触蛋白淀积所特征的疾病。本发明还涉及使用这些新型化合物制备治疗这种神经退行性疾病的药物。本发明还涉及包括这些新型化合物的制药组合物，以及制备这些新型化合物的方法。

  公开号：

  US20120083475A1
• 作为产物：
  描述：

  2-(trimethylsilyloxy)acrylic acid ethyl ester 在 奎宁环 、 三氟化硼乙醚 、 silica gel 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 31.0h， 生成 ethyl 5-phenethyl-4,5-dihydroisoxazole-3-carboxylate
  参考文献：
  名称：

  Organocatalysed synthesis of isoxazolines initiated by a chemoselective oxa-Michael reaction of N-BocNHOH

  摘要：

  报道了一种有机催化、化学选择性的一步氧化迈克尔环化反应，将N-BocNHOH与不饱和α-酮酯反应，为手性富集的3-异恶唑啉羧酸酯衍生物提供了新颖的生物相关杂环骨架合成途径。

  DOI：

  10.1039/c3ob42406e

文献信息

• [EN] INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] DÉRIVÉS D'INDOLAMIDE ET COMPOSÉS ASSOCIÉS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
  申请人：UNIV LEUVEN KATH

  公开号：WO2010142801A1

  公开（公告）日：2010-12-16

  This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

  本发明提供了新型化合物，以及这些新型化合物作为药物的使用，特别是用于预防或治疗神经退行性疾病，更具体地是一些神经系统疾病，例如统称为tauopathies的疾病，以及以细胞毒性α-突触核蛋白淀粉样蛋白生成为特征的疾病。本发明还涉及将所述新型化合物用于制造用于治疗此类神经退行性疾病的药物。本发明还涉及包括所述新型化合物的药物组合物，以及制备所述新型化合物的方法。
• 一种异噁唑啉衍生物的制备方法
  申请人：苏州大学

  公开号：CN107118171B

  公开（公告）日：2019-05-17

  本发明公开了一种异噁唑啉衍生物的制备方法，以烯烃衍生物、重氮衍生物以及亚硝酸叔丁酯为反应底物，以铜化物为催化剂，在碱的条件下，通过金属卡宾与自由基偶联，进一步串联环化反应制备得到异噁唑啉衍生物；本发明设计了一种温和的反应条件，选用原料廉价易得，选用便宜的金属铜化合物为催化剂，直接在封管体系中就可以很方便的合成异噁唑啉衍生物衍生物。避免了传统合成方法使用大量氧化剂，贵金属作为催化剂，无水无氧等苛刻的实验条件，使得反应简单易行，后处理简单，具有潜在的工业应用价值。
• Coupling Reaction of Cu-Based Carbene and Nitroso Radical: A Tandem Reaction To Construct Isoxazolines
  作者：Rongxiang Chen、Yanwei Zhao、Shangwen Fang、Wenhao Long、Hongmei Sun、Xiaobing Wan

  DOI：10.1021/acs.orglett.7b02885

  日期：2017.11.3

  unprecedented cross-coupling reaction between copper carbene and nitroso radical has been developed. This radical-carbene coupling reaction (RCC reaction) offers a novel approach for the preparation of various isoxazolines, which features the construction of C–C, C–O, and C═N bonds in a one-pot process. The synthetic utility of our method is further enhanced by its mild reaction conditions, wide substrate

  在这封信中，已经开发出卡宾铜与亚硝基自由基之间空前的交叉偶联反应。这种自由基-卡宾偶联反应（RCC反应）为制备各种异恶唑啉提供了一种新颖的方法，其特征是通过一锅法构建C–C，C–O和C═N键。温和的反应条件，广泛的底物范围和简单的操作方法进一步提高了我们方法的合成效用。
• Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
  申请人：Griffioen Gerard

  公开号：US08618138B2

  公开（公告）日：2013-12-31

  This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

  本发明提供了新型化合物及其用作药物的新型化合物，更具体地用于预防或治疗神经退行性疾病，更具体地用于某些神经系统疾病，如被称为tau病变的疾病和由细胞毒性α-突触核蛋白淀积引起的疾病。本发明还涉及使用所述新型化合物制备用于治疗此类神经退行性疾病的药物。本发明还涉及包括所述新型化合物的制药组合物以及制备所述新型化合物的方法。
• Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases
  申请人：Katholieke Universiteit Leuven, K.U. Leuven R&D

  公开号：US20190054068A1

  公开（公告）日：2019-02-21

  This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.